West Pharmaceutical Services Inc(WST) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 28 at 4:39 PM ET (Korea 10/29 05:39)
Full metrics table
| Index | S&P 500 | P/E | 51.6 | EPS (ttm) | 7.82 | Insider Own | 0.75% | Shs Outstand | 70.4M | Perf Week | 2.58% |
| Market Cap | 28.41B | Forward P/E | 40.31 | EPS next Y | 11.57% | Insider Trans | -3.54% | Shs Float | 69.8M | Perf Month | 7.17% |
| Enterprise Value | 28.29B | PEG | 2.5 | EPS next Q | 2.2 | Inst Own | 102.62% | Short Float | 2.88% | Perf Quarter | 18.86% |
| Income | 0.56B | P/S | 8.54 | EPS this Y | 23.13% | Inst Trans | -2.04% | Short Ratio | 3.6 | Perf Half Y | 36.66% |
| Sales | 3.33B | P/B | 9.5 | EPS next 5Y | 16.13% | ROA | 14.07% | Short Interest | 2.01M | Perf YTD | 46.7% |
| Book/sh | 42.47 | P/C | 65.18 | EPS past 3/5Y | -4.22% 8.26% | ROE | 19.09% | 52W High | 1.25% ($398.67) | Perf Year | 42.38% |
| Cash/sh | 6.19 | P/FCF | 65.02 | Sales past 3/5Y | 2.14% 7.45% | ROIC | 17.2% | 52W Low | 80.33% ($223.83) | Perf 3Y | 25.78% |
| Dividend Est. | $0.82 (0.2%) | EV/EBITDA | 31 | EPS Y/Y TTM | 17.07% | Gross Margin | 36.82% | Volatility(W/M) | 2.1% 2.17% | Perf 5Y | -4.15% |
| Dividend TTM | 0.88 | EV/Sales | 8.5 | Sales Y/Y TTM | 12.42% | Oper. Margin | 21.97% | ATR (14) | 8.1 | Perf 10Y | 450.67% |
| Dividend Ex-Date | 2026/11/10 | Quick Ratio | 2.12 | EPS Q/Q | 18.81% | Profit Margin | 16.98% | RSI (14) | 75.48 | Recom | 1.37 |
| Dividend Gr. 3/5Y | 5.14% 5.44% | Current Ratio | 2.82 | Sales Q/Q | 13.86% | SMA20 | 6.15% ($380.25) | Beta | 1.15 | Target Price | $421.86 |
| Payout | 12.66% | Debt/Eq | 0.11 | Earnings | 2026/10/29 | SMA50 | 10.54% ($365.15) | Rel Volume | 1.38 | Prev Close | $398.29 |
| Employees | 10800 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | 13.86% 3.85% | SMA200 | 29.39% ($311.96) | Avg Volume(3M) | 0.56M | Price | $403.64 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 15620 | Volume | 772,636 | Change | 1.34% |
🧪 West Pharmaceutical Services (WST) is a global leader in the packaging and delivery systems market for injectable pharmaceuticals. The company manufactures and supplies packaging solutions—such as high-performance elastomer stoppers, vial seals, and self-injection systems—that help ensure the stable storage and administration of high-value medications.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded more than usual. That is 138% of its average volume.
Next earnings report: October 29
1 days to go. The ex-dividend date is November 10.
WST makes money exceptionally well
Of every $100 in sales, $21.97 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +23.1% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $4,031. Peers typically go for $1,950. Compared with its own 5-year average, it is 18% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -4.2%. The S&P 500 did +69% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.20% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 102.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #6 of 51 in the industry
Based on market cap of $28B.
BDX#2 Becton Dickinson & Co $53B PER 58.9 
MDLN#3 Medline Inc $43B PER 38.0 
RMD#4 Resmed Inc $35B PER 24.0 
ALC#5 Alcon Inc $34B PER 53.5 
WST#6 West Pharmaceutical Services Inc $28B PER 51.6 
FAQ
What kind of company is WST?
WST belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of WST?
The market cap of WST is approximately $28.4B, ranking 481 within its sector.
Does WST pay dividends?
WST has a dividend yield of approximately 0.20%, with an annual dividend of $0.82.
What is the P/E ratio of WST?
WST has a P/E ratio of approximately 51.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WST?
WST has recorded a 52-week high of $398.67 and a low of $223.83.
